Executive Summary Japan Pharmaceuticals And Healthcare Industry SWOT Japan Political SWOT Japan Economic SWOT Pharmaceutical Business Environment Ratings Table: Asia Pacific Pharmaceutical Business Environment Rankings, Q208 Limits Of Potential Returns Risks To Realisation Of Returns Japan - Market Summa Regulatory Regime Case Study: Wyeth’s Prevnar and Japanese Drug Lag Recent Regulatory Developments Medical Device Regulations Intellectual Property Developments Pricing And Reimbursement System Table: Reimbursement Categories And Rates Recent Pricing And Reimbursement Developments Other Regulatory Issues Table: Concerns Of Pharmaceutical Associations Industry Trends And Developments Epidemiology Table: Mortality By Cause In Japan Healthcare Sector Healthcare Sector Finance Issues Healthcare Reforms International Collaboration International Reaction Domestic Company Activity Foreign Generic Sector Table: Timeline: Indian Manufacturers In Japan, 2005-2007 Multinational Sector Developments Research And Development Industry Forecast Sce Overall Market Forecast Table: Japanese Ethical Market - Leading Therapeutic Classes, FY05/06 Table: Japan’s Drug Market Indicators Key Growth Factors - Industry Table: Japan’s Healthcare Expenditure Indicators Macroeconomic Forecast Scenario Table: Japan - Macroeconomic Forecasts Prescription Market Forecast Table: Prescription Drug Market Indicators (US$mn unless otherwise stated) OTC Market Forecast Table: OTC Market Indicators (US$mn unless otherwise stated) Generics Market Forecast Table: Generics Market Trends Patented Medicines Market Forecast Table: Patented Medicines Market Indicators Export/Import Forecasts Table: Export/Import Trends (US$mn) Other Healthcare Data And Forecasts Table: Socio-Demographic Indicators Key Risks To our Forecast Scenario Competitive Landscape Table: Japanese Ethical Market - Sales Value (FY2006) Company Profiles Leading Foreign Manufacturers Pfizer Sanofi-Aventis Merck & Co (Banyu) Novartis GlaxoSmithKline (GSK) AstraZeneca Indigenous Manufacturers Takeda Astellas Eisai Daiichi-Sankyo Sawai Pharmaceutical Our Forecast Modelling
How We Generate Our Industry Forecasts Pharmaceutical Industry Pharmaceutical Business Environment Ratings Methodology Ratings Overview Table: Pharmaceutical Business Environment Indicators Weighting Table: Weighting Of Components Sources
